Cargando…
Bradycardia during Induction Therapy with All-trans Retinoic Acid in Patients with Acute Promyelocytic Leukemia: Case Report and Literature Review
A 41-year-old man with newly diagnosed acute promyelocytic leukemia (APL) received induction chemotherapy, containing all-trans retinoic acid (ATRA), idarubicin, and arsenic trioxide. On the 11th day of therapy, he experienced complete atrioventricular (AV) block; therefore, ATRA and arsenic trioxid...
Autores principales: | Chen, Pin-Zi, Wu, Yee-Jen, Wu, Chien-Chih, Wang, Yu-Wen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6011165/ https://www.ncbi.nlm.nih.gov/pubmed/29984015 http://dx.doi.org/10.1155/2018/4938797 |
Ejemplares similares
-
All-trans-retinoic acid–induced pseudotumor cerebri in acute promyelocytic leukemia
por: Anoop, T. M., et al.
Publicado: (2014) -
Multiple adverse drug reactions during all-trans retinoic acid treatment for acute promyelocytic leukemia: differentiation syndrome, bradycardia, intestinal necrosis
por: Ferla, Valeria, et al.
Publicado: (2020) -
SCROTAL ULCERATION FOLLOWING ALL-TRANS RETINOIC ACID THERAPY FOR ACUTE PROMYELOCYTIC LEUKEMIA
por: Tazi, Illias, et al.
Publicado: (2011) -
Sweet’s syndrome during the treatment of acute promyelocytic leukemia with all-trans retinoic acid
por: Park, Chi Jun, et al.
Publicado: (2001) -
All-Trans Retinoic Acid-Induced Pseudotumor Cerebri during Induction Therapy for Acute Promyelocytic Leukemia: A Case Report and Literature Review
por: Holmes, Dylan, et al.
Publicado: (2012)